The bioprocessing track provides a technical forum for biopharmaceutical development, bioprocessing and manufacturing strategies.
It includes downstream processing, addressing key issues in continuous processing, single-use technology, chromatography, automation and analytics to make the purification of biologics more efficient and cost effective.
Bo Kara, Head Process Development, Advanced Therapy Delivery, GSK
Otto-Wilhelm Merten, Head of the Applied Vectorology and Innovation Group, Généthon
Nicolas Urbieta, USP Scientist, Sanofi
Katy Spink, Chief Operating Officer, Asterias Biotherapeutics
James Leverone, Head of Process Engineering and Validation, ImmunoGen
Dylan Jones, Principal Scientist, Genzyme
Manuel Carrondo, Professor of Chemical & Biochemical Engineering, FCT-UNL, Vice-President, IBET
Qasim Rafiq, Senior Lecturer (Associate Professor), Bioprocessing of Regenerative, Cellular and Gene Therapies, Department of Biochemical Engineering, UCL
The World Advanced Therapies and Regenerative Medicine Congress looks at the precision medicine pipeline, from early discovery and development of drugs and diagnostics, through to implementation in clinics and hospitals.
Ethics, regulations and patient advocacy and involvement is also explored, with talks, roundtables and panels being run by top senior executives, clinicians, academics and thought leaders.
With the new addition of AI in Healthcare, the congress is expanding to include some of the most exciting uses of technology for genomic medicine, patient management and data handling.